Umeclidinium
Incruse Ellipta
NADAC/unit
$10.2598
No Shortage
Tier 1: 12.5%
ANORO ELLIPTA is indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).
vs. brand Incruse Ellipta: Generic saves up to -3% per unit
Generic Manufacturers
GLAXO GROUP LTD ENGLAND DBA GLAXOSMITHKLINE
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.